Personalized medicine: importance of clinical interpretative skills for real-world patient care

被引:0
|
作者
Gryn, Steven E. [1 ]
Kim, Richard B. [1 ]
机构
[1] Univ Western Ontario, Div Clin Pharmacol, Dept Med, London Hlth Sci Centre UH, London, ON N6A 5A5, Canada
基金
加拿大健康研究院;
关键词
azathioprine; clinical pharmacology; clopidogrel; metoprolol; pharmacogenetics; pharmacogenomics; statin; warfarin; IMPLEMENTATION CONSORTIUM GUIDELINES; PERCUTANEOUS CORONARY INTERVENTION; CYP2C19; GENOTYPE; BREAST-CANCER; COST-EFFECTIVENESS; ACTIVE METABOLITE; CYP2D6; CARDIOVASCULAR OUTCOMES; ANTIPLATELET THERAPY; PLATELET REACTIVITY;
D O I
10.2217/PME.14.16
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Sequencing of the human genome led to great hopes and expectations for a 'genomics revolution' where disease diagnosis as well as therapies would be based on an individual's genetic makeup. Although significant progress has been made, a number of challenging hurdles must be overcome prior to the broader adoption and implementation of pharmacogenomics and personalized medicine as a part of standard patient care. One aspect of pharmacogenomics-based personalized medicine that has not garnered as much attention, a key focus of this perspective, is the importance of interpreting pharmacogenomic test results in a patient-specific clinical context, and expert physicians and other allied health care providers with the requisite expertise in clinical pharmacology and genomics who are able to provide such services.
引用
收藏
页码:395 / 408
页数:14
相关论文
共 50 条
  • [41] Ambulatory Hemodynamic Monitoring Reduces Heart Failure Hospitalizations in "Real-World" Clinical Practice
    Desai, Akshay S.
    Bhimaraj, Arvind
    Bharmi, Rupinder
    Jermyn, Rita
    Bhatt, Kunjan
    Shavelle, David
    Redfield, Margaret M.
    Hull, Robert
    Pelzel, Jamie
    Davis, Kevin
    Dalal, Nirav
    Adamson, Philip B.
    Heywood, Thomas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (19) : 2357 - 2365
  • [42] Genetic Ancestry Correlates with Somatic Differences in a Real-World Clinical Cancer Sequencing Cohort
    Arora, Kanika
    Tran, Thinh N.
    Kemel, Yelena
    Mehine, Miika
    Liu, Ying L.
    Nandakumar, Subhiksha
    Smith, Shaleigh A.
    Brannon, A. Rose
    Ostrovnaya, Irina
    Stopsack, Konrad H.
    Razavi, Pedram
    Safonov, Anton
    Rizvi, Hira A.
    Hellmann, Matthew D.
    Vijai, Joseph
    Reynolds, Thomas C.
    Fagin, James A.
    Carrot-Zhang, Jian
    Offit, Kennet
    Solit, David B.
    Ladanyil, Marc
    Schultz, Nikolaus
    Zehir, Ahmet
    Brown, Carol L.
    Stadler, Zsofia K.
    Chakravarty, Debyani
    Bandlamudi, Chaitanya
    Berger, Michael F.
    CANCER DISCOVERY, 2022, 12 (11) : 2552 - 2565
  • [43] Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies First Results From the RCT DUPLICATE Initiative
    Franklin, Jessica M.
    Patorno, Elisabetta
    Desai, Rishi J.
    Glynn, Robert J.
    Martin, David
    Quinto, Kenneth
    Pawar, Ajinkya
    Bessette, Lily G.
    Lee, Hemin
    Garry, Elizabeth M.
    Gautam, Nileesa
    Schneeweiss, Sebastian
    CIRCULATION, 2021, 143 (10) : 1002 - 1013
  • [44] Feasibility and User Experience of Digital Patient Monitoring for Real-World Patients With Lung or Breast Cancer
    Arriola, Edurne
    Jaal, Jana
    Edvardsen, Anne
    Silvoniemi, Maria
    Araujo, Antonio
    Vikstrom, Anders
    Zairi, Eleni
    Rodriguez-Mues, Mari Carmen
    Roccato, Marco
    Schneider, Sophie
    Ammann, Johannes
    ONCOLOGIST, 2024, 29 (04) : e561 - e569
  • [45] Interim analysis of a real-world precision medicine platform for molecular profiling of metastatic or advanced cancers: MONDTI
    Kieler, Markus
    Unseld, Matthias
    Bianconi, Daniela
    Waneck, Fredrik
    Mader, Robert
    Wrba, Fritz
    Fuereder, Thorsten
    Marosi, Christine
    Raderer, Markus
    Staber, Philipp
    Berger, Walter
    Sibilia, Maria
    Polterauer, Stephan
    Muellauer, Leonhard
    Preusser, Matthias
    Zielinski, Christoph C.
    Prager, Gerald W.
    ESMO OPEN, 2019, 4 (04)
  • [46] Real-world use of multigene signatures in early breast cancer: differences to clinical trials
    Licata, Luca
    De Sanctis, Rita
    Vingiani, Andrea
    Cosentini, Deborah
    Iorfida, Monica
    Caremoli, Elena Rota
    Sassi, Isabella
    Fernandes, Bethania
    Gianatti, Andrea
    Guerini-Rocco, Elena
    Zambelli, Claudia
    Munzone, Elisabetta
    Simoncini, Edda Lucia
    Tondini, Carlo
    Gentilini, Oreste Davide
    Zambelli, Alberto
    Pruneri, Giancarlo
    Bianchini, Giampaolo
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (01) : 39 - 48
  • [47] Real-world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program
    Wharton, Sean
    Haase, Christiane L.
    Kamran, Elham
    Liu, Aiden
    Mancini, Johanna
    Neish, Drew
    Pakseresht, Arash
    Power, G. Sarah
    Christensen, Rebecca A. G.
    OBESITY SCIENCE & PRACTICE, 2020, 6 (04): : 382 - 389
  • [48] Why Strive after Clinical Social Medicine? From Epidemiological Association to Personalized Social Medicine: a Case of Breast Cancer Care
    Simoes, E.
    Sokolov, A. N.
    Graf, J.
    Pavlova, M. A.
    Brucker, S. Y.
    Wallwiener, D.
    Schmahl, F. W.
    Bamberg, M.
    GESUNDHEITSWESEN, 2016, 78 (02) : 97 - 102
  • [49] Screening Results for Diabetic Retinopathy in Germany in a Real-world Cohort in a Metropolitan Diabetes Care Center
    Mertes, Bernardo
    Kuniss, Nadine
    Piorkowski, Michael
    Mertes, Linus Paul
    Hammes, Hans-Peter
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2023, 131 (04) : 182 - 186
  • [50] Therapeutic Advances in Obesity: How Real-World Evidence Impacts Affordability Beyond Standard of Care
    Patoulias, Dimitrios
    Koufakis, Theocharis
    Ruza, Ieva
    El-Tanani, Mohamed
    Rizzo, Manfredi
    PRAGMATIC AND OBSERVATIONAL RESEARCH, 2024, 15 : 139 - 149